Strategy's STRC preferred shares reached $100 for the first time since May, following months of share buybacks and a recent shift to daily dividend payments starting November 1. This milestone is significant because trading at or above $100 allows Strategy to issue new STRC shares to raise funds for bitcoin purchases, reversing prior buyback efforts. The shares offer a 12% annualized dividend yield, now accrued daily to reduce price swings and attract income-focused investors. While crossing $100 enables new share issuance, actual transactions depend on management decisions and market conditions.
Bitcoin Giant Strategy's STRC shares hit $100 for the first time since May, a key threshold for new share issuance. For readers following the broader cryptocurrency market, here is Pluang's snapshot as of Nov 05, 2026 00:31 WIB: out of 50 major cryptocurrencies, 45 rose and 4 fell. Among notable movers, GRT rose 4.23% to Rp375 with a typical hold time of 100 days and a 71% sell order activity, while AXS gained 4.18% to Rp15,957 with 100% buy order activity and a 63-day hold time. LINK increased 4.02% to Rp209,625, with 74% buy activity and a 64-day hold time.
Goldman Sachs Group, Inc. disclosed that it briefly held a combined stake exceeding 3% in Ontex Group NV shares as of October 27, 2026, with 566,115 voting rights and 1,965,157 financial instruments. However, by October 28, 2026, their combined posit...
BNP Paribas announced its monthly declaration of voting rights and shares as of October 31, 2026. The bank reported a total of 1,101,600,607 shares and an equal number of voting rights. This update is part of regulatory compliance under French commer...
Ontex disclosed that Goldman Sachs Group, Inc. crossed the 3% ownership threshold in Ontex shares on October 27, 2026, holding a combined total of 3.07% including voting rights and financial instruments. However, the next day, October 28, 2026, Goldm...
Neion Bio has appointed John A. Maga, Ph.D., as Head of Biologics and CMC to lead the development of biologic medicines using its Raptor platform, which produces proteins in transgenic chicken eggs. Maga brings over 25 years of biopharmaceutical expe...
The National Advertising Division (NAD) recommended that Good Life Meds discontinue claims about health benefits and personalization for its compounded Tirzepatide+ weight loss products after a challenge by Eli Lilly. NAD found that Good Life lacked ...
